Fellow Floridian and myeloma survivor, Gary Petersen, hosts a website, MyelomaSurvival.com. On it, Gary stresses how important it is to be treated somewhere that specializes in multiple myeloma. In a feature article that ran on MedPage Today after ASH last month, myeloma specialist, Dr. Noopur Raje, agrees:
“What it really tells me is that some of [survival may have] to do with access to drugs and access to therapies,” she said. Access to the latest treatments is more likely at academic centers, she noted.
The clinical implication for patients is that “if you have a center which focuses on this disease, go to that site,” she said.
I personally know and respect Dr. Raje, who splits time as a researcher and clinician at the Massachusetts General Hospital Cancer Center in Boston.
Dr. Raje is quoted at the end of the article; I’m going to reproduce it below. But be warned. MedPage Today’s Michael Smith doesn’t sugar coat anything when referring to overall survival rates:
Tx, Transplant Predict Multiple Myeloma Survival
Published: Dec 12, 2013 | Updated: Dec 13, 2013